about
Non-Alcoholic Fatty Liver Disease and Extra-Hepatic CancersHepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative ActivitiesGut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of MetabolomicsOxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-AcetylcysteineStrategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.Cystic fibrosis related liver disease--another black box in hepatology.Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.Pathobiology of liver fibrosis: a translational success storyGut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women.The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood.Inflammasomes and the microbiota--partners in the preservation of mucosal homeostasis.Toll-like receptor 5 in obesity: the role of gut microbiota and adipose tissue inflammation.The effect of sampling and storage on the fecal microbiota composition in healthy and diseased subjects.The promise of metabolic phenotyping in gastroenterology and hepatology.Proton pump inhibitors affect the gut microbiome.Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat dietNaturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis.Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization.Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression.Antifibrotic therapies in the liver.Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?Inflammasome activation and function in liver disease.Nonalcoholic fatty liver disease - current status and future directions.Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications.Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling.The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease.Aguamiel concentrate from Agave salmiana and its extracted saponins attenuated obesity and hepatic steatosis and increased Akkermansia muciniphila in C57BL6 miceGut Microbiota: Association with NAFLD and Metabolic Disturbances.Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study.Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD.Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitisNonalcoholic fatty liver disease: Evolving paradigms.Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift.Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.
P2860
Q26749045-76CBAC2C-66F1-4D37-AB07-3C5625638040Q26752622-26ED1B5B-5A29-4BDE-931E-8CCD0F2AE2F2Q26753047-C75C8268-78E4-4E3D-8883-B45559B4A7AEQ26773384-1C4D96B9-42D4-4C38-BE99-FC12D9473CB4Q28082065-01D839EC-0990-4CE5-96A9-605A15B1B018Q28655881-5647383E-9652-4FB7-8C23-4D4C9BF43C6CQ30235846-F9C2058A-DE64-4FEB-AB41-790E93414F7CQ33714116-D71D6CA5-B3A8-440B-8E1F-003F050DFFD2Q34462733-4717A639-D0F2-4ADC-B47F-83946A77ABD6Q34499017-DA3EF54C-9FCE-466A-9DA4-A99DA7EC158CQ34502294-0A484B13-87C5-4804-AFA0-AC96D2EB8B67Q35147544-43C70F1D-DCF6-4D1D-A05E-D45F853191A9Q35332035-1D364ED0-F64B-4AC2-A081-3A2051FB0183Q35547292-94AC5672-11D7-48AA-A224-A0041B4E6D88Q35646146-A507EF86-5C4E-4112-86E2-142DFC6F2A11Q35701279-BF3D77AA-3260-490B-89B8-21B9646B37B3Q35866595-689D5FBA-CE9B-4F5E-9C10-CD2D94D6D9C8Q36049267-AFD795C1-060F-4826-9F5E-42132792F937Q36170809-EB03E1AC-4D37-4CFB-B763-46922343E59EQ36196897-129B13CD-59EC-4079-ACEE-E009DDCD8A0AQ36952218-F42282D4-3DFE-4FEE-8BEE-6547D8DC8B78Q37357860-3D0C00CC-6D5D-47E4-B197-16C9F9BA2730Q37563673-533E637D-D5BA-4690-A0FB-C7462D2953FEQ38480164-37A841BB-742A-430A-AA2B-9A36EBED9C12Q38500120-113CF49F-9A63-42C0-849A-180907B52EFDQ38521274-AB743933-D3D9-405C-8F3A-7777966B54FCQ38592767-11B008CD-E3AA-43F3-91C0-C735044A0B49Q38606360-CA8C21E0-7777-4B3F-A61E-0D27A8048F04Q38665591-3D4E0D06-1A5A-4977-88E2-D0F6135B383EQ39099711-16508386-F906-4C82-8320-91A83472BE81Q40176500-A4FB4455-4B82-4683-B9AD-231FD0062E23Q40897334-B836CDFB-D09E-41F7-ABA4-C08524F83783Q41203375-8FF4A2B1-2875-4606-ADE5-2B3B49B8A417Q41564230-A34A5ECA-7485-48FE-AB9B-BB996993173BQ41614727-472F1FB6-7F6B-4807-A41A-F15C9864825DQ42172913-B6B9DFE5-C58A-4205-9D18-CBB13D0B0350Q42369219-6C1CE77F-37D2-4344-9FF0-6C2933BBE1C7Q42695154-285F558F-87F2-44E5-AF4E-DA14007CAB3EQ47105075-ABFE0992-6EE8-4C3E-936D-DC8AAF61D162Q47116789-478BC762-452A-4C0E-A7A7-F66697222A56
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The Gordian Knot of dysbiosis, obesity and NAFLD.
@ast
The Gordian Knot of dysbiosis, obesity and NAFLD.
@en
The Gordian Knot of dysbiosis, obesity and NAFLD.
@nl
type
label
The Gordian Knot of dysbiosis, obesity and NAFLD.
@ast
The Gordian Knot of dysbiosis, obesity and NAFLD.
@en
The Gordian Knot of dysbiosis, obesity and NAFLD.
@nl
prefLabel
The Gordian Knot of dysbiosis, obesity and NAFLD.
@ast
The Gordian Knot of dysbiosis, obesity and NAFLD.
@en
The Gordian Knot of dysbiosis, obesity and NAFLD.
@nl
P2860
P1476
The Gordian Knot of dysbiosis, obesity and NAFLD.
@en
P2093
Wajahat Z Mehal
P2860
P2888
P304
P356
10.1038/NRGASTRO.2013.146
P407
P577
2013-08-20T00:00:00Z